Product details - Bovilis® IBR marker inac

Description
Bovilis® IBR marker inac is an inactivated marker vaccine against infections with Bovine herpesvirus type 1 in cattle. Bovine herpesvirus type 1 (BoHV-1) the causative agent of infectious bovine rhinotracheitis (IBR).

Composition
Each dose contains at least 60 ELISA units for induction of 6.1 - 11.1 log2 VN-units in mouse potency test of gE- BoHV-1 strain GK/D.

Indications
Bovilis IBR marker inac is used for active immunisation of cattle to reduce the intensity and duration of clinical signs (pyrexia) induced by an infection with BoHV-1 as well as to reduce the replication and nasal excretion of the field virus

Vaccination
Intramuscular injection
Dosage 2 ml per animal.

Method of administration
All animals can be vaccinated from an age of three months onward.
Basic vaccination:

• Two doses of 2ml each with an interval of 4 weeks

Re-vaccination (after basic vaccination with Bovilis IBR marker inac or with the live Intervet BoHV-1 marker vaccine):

• One dose of 2ml every 6 months

Side reactions
No clinical reactions. Occasionally a hypersensitivity reaction may occur. In such cases an appropriate symptomatic treatment should be administered. At the injection site a local reaction may occur.

Withholding period
None. (National regulations should be observed).

Presentation
Hydrolytical glass type I (PhEur) or polyethylene-terephthalate (PET) vials with 5, 10, 25, 50 or 100 doses

Storage
Store at the temperature between 2-8°C. Do not freeze.

Further information
The vaccine does not elicit antibodies to glycoprotein E of BoHV-1 (marker vaccine). This enables discrimination between cattle vaccinated with the product and cattle infected with BoHV-1 field virus.

Precautions
Vaccinate healthy animals only.